OConnell Daniel Joseph
Acumen Pharmaceuticals, Inc. · Chief Executive Officer
OConnell Daniel Joseph is listed in filings as Chief Executive Officer at Acumen Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 23, 2026, including sale activity. Recent filings connect the profile to Acumen Pharmaceuticals, Inc. (ABOS). The current snapshot covers public activity from Jan 7, 2025 to Jan 23, 2026. Reported amounts are shown as $5.1K to $837.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $17k9.3k shares | SellJan 21, 2026 | $1.81 | $2.54 | |
| $9.3k5.4k shares | SellJan 12, 2026 | $1.73 | $2.54 | |
| $23k12.9k shares | SellJan 9, 2026 | $1.76 | $2.54 | |
| $15k8.1k shares | SellJan 8, 2026 | $1.82 | $2.54 | |
| $75k37.8k shares | SellJan 7, 2026 | $1.99 | $2.54 | |
| $10k5.1k shares | SellJan 6, 2026 | $1.97 | $2.54 | |
| $9.2k4.6k shares | SellJan 5, 2026 | $1.97 | $2.54 | |
| $20k12.6k shares | SellJan 21, 2025 | $1.59 | $2.54 | |
| $88k47.8k shares | SellJan 3, 2025 | $1.84 | $2.54 |